ABALOPARATIDE and VOMITING

Overview

VOMITING is the #18 most commonly reported adverse reaction for ABALOPARATIDE, manufactured by Radius Health, Inc.. There are 740 FDA adverse event reports linking ABALOPARATIDE to VOMITING. This represents approximately 1.3% of all 58,437 adverse event reports for this drug.

Patients taking ABALOPARATIDE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING is a less commonly reported adverse event for ABALOPARATIDE, but still significant enough to appear in the safety profile.

Other Side Effects of ABALOPARATIDE

In addition to vomiting, the following adverse reactions have been reported for ABALOPARATIDE:

• HEADACHE — 4,180 reports
• NAUSEA — 3,222 reports
• DIZZINESS — 3,122 reports
• FATIGUE — 2,742 reports
• HEART RATE INCREASED — 2,139 reports
• ARTHRALGIA — 1,802 reports
• PALPITATIONS — 1,785 reports
• BONE PAIN — 1,414 reports
• BACK PAIN — 1,289 reports
• PAIN — 1,269 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

Does ABALOPARATIDE cause VOMITING?

VOMITING has been reported as an adverse event in 740 FDA reports for ABALOPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with ABALOPARATIDE?

VOMITING accounts for approximately 1.3% of all adverse event reports for ABALOPARATIDE, making it a notable side effect.

What should I do if I experience VOMITING while taking ABALOPARATIDE?

If you experience vomiting while taking ABALOPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages